Clinical evidences showed that Sp1 is over-expressed in a number of cancers and have been show to correlate with cancer cell migration and metastasis via the regulation of EMT in various cancers, such as gastric [7], pancreatic [8], breast cancers [9] and hepatocellular carcinoma [10]. Here, SP1 is linked to breast carcinoma.